ArticleFrontiers in oncology2021

Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series.

Shuang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.